Fairvalue-Calculator Fairvalue-Calculator
EN DE

Zhejiang Jiuzhou Pharmaceutical Co (603456) Fair Value & Analysis

Healthcare · CN · Market cap 11.4B CNY

Price¥12.91
Fair Value¥20.89
Upside+61.8%
Quality94/100
Evidence: High Range ¥15.48 – ¥26.30

Fair value as of: Jun 24, 2026

Analysis

Zhejiang Jiuzhou Pharmaceutical Co (603456) currently trades at ¥12.91, while our model-based Fair Value estimate is ¥20.89 — implying the stock looks roughly 61.8% undervalued today. We read business quality at 94/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecule, drug product, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1949% Jiangsu Hengrui Pharmaceuticals Co (600276) -46% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -74% Hansoh Pharmaceutical Group (3692) -47% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is Zhejiang Jiuzhou Pharmaceutical Co (603456) undervalued?
As of Jun 24, 2026, our model estimates a fair value of ¥20.89 versus a price of ¥12.91 — about +62% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 603456?
Our 21-model fair value for Zhejiang Jiuzhou Pharmaceutical Co is ¥20.89 (as of Jun 24, 2026), built from audited fundamentals. The current price is ¥12.91.
What is the quality score of 603456?
Zhejiang Jiuzhou Pharmaceutical Co has a Quality Score of 94/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.